| Literature DB >> 29681942 |
Abebaw Bitew Kifilie1, Mulat Dagnew2, Birhanemeskel Tegenie2, Biruk Yeshitela3, Rawleigh Howe3, Ebba Abate4.
Abstract
INTRODUCTION: Surgical site infection is a vital cause of maternal mortality and morbidity, especially in resource-limited countries. The rise of antibiotic resistance bacterial infection poses a big threat to this vulnerable population. However, there is lack of studies around the study area.Entities:
Year: 2018 PMID: 29681942 PMCID: PMC5845495 DOI: 10.1155/2018/3165391
Source DB: PubMed Journal: Int J Microbiol
Sociodemographic, obstetric, and clinical variables from women attending antenatal and postnatal services at the University of Gondar Teaching Hospital from 1 January 2016 to 30 May 2016.
| Characteristics | Number (%) |
|---|---|
| Age (years) | |
| 15–24 | 39 (36.5%) |
| 25–34 | 56 (52.3%) |
| 35–44 | 12 (11.2%) |
| Residence | |
| Urban | 83 (77.6%) |
| Rural | 24 (23.4%) |
| Religion | |
| Orthodox | 97 (90.7%) |
| Muslim | 7 (6.5%) |
| Protestant | 3 (2.8%) |
| Marital status | |
| Married | 105 (98.1) |
| Single | 2 (1.9%) |
| Educational level | |
| Illiterate | 35 (32.7%) |
| Primary school (1–8) | 14 (13.1%) |
| Secondary school | 31 (29.0%) |
| Higher education | 27 (25.2%) |
| Occupational status | |
| Housewives | 65 (60.7%) |
| Self-employees | 17 (15.9%) |
| Government employees | 20 (18.7%) |
| Students | 3 (2.8%) |
| Daily laborer | 2 (1.9%) |
| Gravidity | |
| 1–3 | 95 (88.8%) |
| 4–6 | 10 (9.3%) |
| 7–9 | 2 (1.9%) |
| Prolonged labour | |
| Yes | 52 (48.6) |
| No | 55 (51.4%) |
| Premature rapture of membrane | |
| Yes | 43 (40.2%) |
| No | 64 (59.8%) |
| Mode of delivery | |
| Vaginal delivery | 69 (41.3%) |
| Cesarean delivery | 81 (48.5%) |
| Instrumental delivery | 17 (10.2%) |
| Place of delivery | |
| Health institution | 107 (100%) |
| Diabetes mellitus | |
| No | 98 (91.6%) |
| Yes | 9 (8.4%) |
| HIV/AIDS | |
| No | 103 (96.3%) |
| Yes | 4 (3.7%) |
HIV: human immunodeficiency virus.
Figure 1Profile and frequency of bacterial isolates from women having SSI during postnatal period at the University of Gondar Teaching Hospital from 1 January 2016 to 30 May 2016.
Antibacterial susceptibility pattern for Gram-positive SSI causing pathogens from women attending postnatal service at University of Gondar Teaching Hospital from 1 January 2016 to 30 May 2016.
| Bacterial isolates | Antibacterial susceptibility pattern | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMO | CRO | P | CAZ | SXT | CXM | CXC | DA | CXT | ||
|
| S% | 12 (28.6) | 14 (33.3) | 27 (64.3) | 21 (50) | 24 (57.1) | 16 (38.1) | 31 (73.8) | 20 (47.6) | 35 (83.3) | 35 (83.3) |
| R% | 30 (71.4) | 28 (66.7) | 15 (35.7) | 21 (50) | 18 (42.9) | 26 (61.9) | 11 (26.2) | 22 (52.4) | 7 (16.7) | 7 (16.7) | |
|
| S% | 2 (15.4) | 2 (14.3) | 8 (61.5) | 5 (38.5) | 8 (61.5) | 5 (38.5) | 10 (76.9) | 8 (61.5) | 12 (92.3) | 11 (84.6) |
| R% | 11 (84.6) | 11 (85.7) | 5 (38.5) | 8 (61.5) | 5 (38.5) | 8 (61.5) | 3 (23.1) | 5 (38.5) | 1 (7.7) | 2 (15.4) | |
|
| S% | 0 (0) | 1 (50) | 4 (100) | 2 (100) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) |
| R% | 2 (100) | 1 (50) | 0 (0) | 0 (0) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | 1 (50) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
P: penicillin; CAZ: ceftazidime; CXM: cefixime; CXC: cloxacillin; CD: clindamycin; CXT: cefoxitin; S. pyogenes: Streptococcus pyogenes.
Antibacterial susceptibility pattern for Gram-negative SSI causing pathogens from women attending postnatal service at University of Gondar Teaching Hospital from 1 January 2016 to 30 May 2016.
| Bacterial isolates | Antibacterial susceptibility pattern | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMX | AMP | CRO | CIP | CXT | CAZ | SXT | CXM | GEN | NA | AMK | TTC | ||
|
| S% | 6 (30) | 4 (20) | 8 (40) | 16 (80) | 16 (80) | 12 (60) | 10 (50) | 15 (75) | 13 (65) | 15 (75) | 19 (95) | 6 (30) |
| R% | 14 (70) | 16 (80) | 12 (60) | 4 (20) | 4 (20) | 8 (40) | 10 (50) | 5 (25) | 7 (35) | 5 (25) | 1 (5) | 14 (70) | |
|
| S% | 0 (0) | 0 (0) | 6 (42.9) | 12 (85.7) | 13 (92.9) | 10 (71.4) | 5 (35.7) | 11 (78.6) | 11 (78.6) | 13 (92.9) | 14 (100) | 2 (14.3) |
| R% | 14 (100) | 14 (100) | 8 (57.1) | 2 (14.3) | 1 (7.1) | 4 (28.6) | 9 (64.3) | 3 (21.4) | 3 (21.4) | 1 (7.1) | 0 (0) | 12 (86) | |
|
| S% | 2 (50) | 0 (0) | 4 (100) | 4 (100) | 2 (50) | 2 (50) | 3 (75) | 2 (50) | 2 (50) | 3 (75) | 3 (75) | 2 (50) |
| R% | 2 (50) | 4 (100) | 0 (0) | 0 (0) | 2 (50) | 2 (50) | 1 (25) | 2 (50) | 2 (50) | 1 (25) | 1 (25) | 2 (50) | |
|
| S% | 1 (25) | 1 (25) | 3 (25) | 3 (75) | 4 (100) | 3 (75) | 2 (50) | 4 (100) | 3 (75) | 3 (75) | 4 (100) | 2 (50) |
| R% | 3 (75) | 3 (75) | 1 (25) | 1 (25) | 0 (0) | 1 (25) | 2 (50) | 0 (0) | 1 (25) | 1 (25) | 0 (0) | 2 (50) | |
| S% | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | |
| R% | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0 (0) | (0) | 1 (100) | |
|
| S% | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) |
| R% | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
CIP: ciprofloxacin; GEN: gentamycin; AMK: amikacin; NA: nalidixic acid; TTC: tetracycline; SXT: sulfamethoxazole trimethoprim; R: resistance; S: sensitivity.
Bivariate and multivariate analysis for the assessment of factors associated with bacterial infection from women attending antenatal and postnatal service at the University of Gondar Teaching Hospital from 1 January 2016 to 30 May 2016.
| Characteristics | Culture | Bivariate analysis | Multivariate analysis |
| |
|---|---|---|---|---|---|
| Positive number (%) | Negative number (%) | COR (95% CI) | AOR (95% CI) | ||
| Age | |||||
| 15–24 | 34 (37.8) | 5 (29.4) | 1 | ||
| 25–34 | 49 (54,4) | 7 ( 41.2) | 2.267 (0.454, 11.327) | ||
| 35–44 | 7 (7.8) | 5 (29.4) | 1.741 (0.393, 7.713) | ||
| Residence | |||||
| Urban | 70 (77.8) | 13 (76.5) | 0.923 (0.273, 3.164) | ||
| Rural | 20 (22.2) | 4 (23.5) | 1 | ||
| Occupation | |||||
| Self-employer | 85 (94,4) | 17 (100) | 1 | ||
| Government | 5 (5.6) | 0 (0) | 0.982 (0.585, 1.648) | ||
| Education | |||||
| Illiterate | 28 (31.1) | 7 (41.2) | 1 | ||
| Primary | 12 (13.3) | 2 (11.8) | 0.696 (0.181, 2.674) | ||
| Secondary | 27 (30) | 4 (23.5) | 1.043 (0.167, 6.59) | ||
| Higher education | 23 (25.6) | 4 (23.5) | 1.174 (0.264, 5.226) | ||
| Marital status | |||||
| Married | 88 (97.8) | 17 (100) | 1 | ||
| Single | 2 (2.2) | 0 (0) | 0.691 (0.227, 2.101) | ||
| Mode of delivery | |||||
| VDE | 34 (37.8) | 3 (17.6) | 15.111 (3.095, 73.77) | 102 (5.2, 2028) | 0.002 |
| C/S | 50 (55.6) | 6 (35.3) | 11.111 (2.865, 43.099) | 86 (5, 1436) | 0.002 |
| Instrumental | 6 (6.7) | 8 (47.1) | 1 | ||
| Prolonged labour | |||||
| No | 45 (50) | 10 (58.8) | 1 | ||
| Yes | 45 (50) | 7 (41.2) | 0.700 (0.245, 2.001) | ||
| PRM | |||||
| No | 50 (55.6) | 14 (82.4) | 1 | ||
| Yes | 40 (44.4) | 3 (17.6) | 0.268 (0.072, 0.997) | 0.012 (0.001, 0.305) | 0.008 |
| Gravidity | |||||
| 1–3 | 80 (88.9) | 15 (88.2) | 1.746 (0.513, 5.940) | ||
| 4–6 | 9 (10) | 1 (5.9) | 1.290 (0.343, 4.856) | ||
| 7–9 | 1 (1.1) | 1 (5.9) | 1 | ||
Note. ∗ indicates statistical significance at p ≤ 0.05, in both bivariate and multivariate analyses. AOR: adjusted odds ratio; COR: crude odds ratio; 1: reference group; 95% CI: 95% confidence interval; UTI: urinary tract infection; C/S: cesarean section; VDE: vaginal delivery with episiotomy; PRM: premature rapture of membrane.
| Antibiograms | Gram-negative bacterial isolates | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Total = | = 20 | = 14 | = (4) | = (4) | = 1 |
| |
| AMP, TTC | 5 (11.4) | 2 (10) | 3 (21.4) | — | — | — | — |
| AMO, SXT | 1 (2.3) | — | 1 (11.1) | — | — | — | — |
| AMP, TTC, GEN | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMP, TTC, SXT | 3 (6.8) | 1 (5) | 2 (14.3) | — | — | — | — |
| AMO, SXT, CRO | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMX, TTC, CRO | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMX, TTC, CRO | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMX, CRO, GEN, TTC | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMX, TTC, SXT, CRO | 5 (11.4) | 1 (5) | 2 (14.3) | — | 1 (25) | — | 1 (100) |
| AMP, SXT, CRO, NAL | 2 (4.5) | 2 (10) | — | — | — | — | — |
| AMO, SXT, CXM, TTC | 1 (2.3) | — | — | 1 (25) | — | — | — |
| AMO, CPR, CRO, NAL | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMO, TTC, SXT, GEN, CRO | 4 (9.1) | 1 (5) | 3 (21.4) | — | — | — | — |
| AMO, CXM, AMK, TTC, NAL | 1 (2.3) | — | — | 1 (25) | — | — | — |
| AMO, SXT, CXM, GEN, TTC | 1 (2.3) | — | — | — | — | 1 (100) | — |
| AMO, CRO, CPR, SXT, TTC, NAL | 1 (2.3) | 1 (5) | — | — | — | — | — |
| AMO, CPR, SXT, CXM, TTC, NAL | 1 (2.3) | — | 1 (11.1) | — | — | — | — |
| AMO, CRO, CPR, SXT, GEN, TTC, NAL | 3 (6.8) | 2 (10) | — | — | 1 (25) | — | — |
|
| |||||||
|
|
|
|
|
|
|
|
|
| Antibiograms | Gram-positive bacterial isolates | |||
|---|---|---|---|---|
| Total = 57 |
| CoNS = 13 |
| |
| P, CXM | 1 (1.8) | 1 (2.4) | — | — |
| P, CRO | 1 (1.8) | — | 1 (7.7) | — |
| AMP, CXC | 2 (3.5) | 1 (2.4) | 1 (7.7) | — |
| AMP, CAZ | 2 (3.5) | 1 (4.8) | 1 (7.7) | — |
| AMO, SXT | 6 (10.5) | 5 (11.9) | 1 (7.7) | — |
| P, CRO, SXT | 1 (1.8) | 1 (2.4) | — | — |
| AMP, SXT, CAZ | 3 (5.3) | 1 (2.4) | 2 (15.4) | — |
| AMO, CAZ, CXC | 3 (5.3) | 3 (7.1) | — | — |
| AMO, CRO, CXC | 4 (7) | 4 (9.5) | — | — |
| AMO, CRO, SXT | 2 (3.5) | 2 (4.8) | — | — |
| AMP, SXT, CXC | 2 (3.5) | 1 (2.4) | 1 (7.7) | — |
| P, SXT, CXC, CD | 2 (3.5) | 2 (4.8) | — | — |
| P, CRO, SXT, CXC | 6 (10.5) | 4 (9.5) | 2 (15.4) | — |
| AMP, CAZ, SXT, CXC | 4 (7) | 2 (4.8) | 1 (7.7) | 1 (50) |
| AMP, CRO, CXC, SXT | 3 (5.3) | 3 (7.1) | — | — |
| P, CRO, SXT, CXC, DA | 1 (1.8) | 1 (2.4) | — | — |
| P, SXT, CAZ, CXC, DA | 2 (3.5) | 1 (2.4) | 1 (7.7) | — |
| AMO, CRO, SXT, CXC, DA | 2 (3.5) | 2 (4.8) | — | — |
|
| ||||
|
|
|
|
|
|
TTC: tetracycline; GEN: gentamycin; NA: nalidixic acid; CPR: ciprofloxacin; CoNS: coagulase negative Staphylococcus species; GAS: group A Streptococcuspyogenes; CD: clindamycin; CXC: cloxacillin.